April 30, 2018 07:54 AM EDTUpdated 08:14 AM
People

Who’s the top earn­ing CEO in bio­phar­ma? Mar­tine Roth­blatt once again hits top slot with $37M pay pack­age

John Carroll

Editor & Founder

For­get Al­ler­gan CEO Brent Saun­ders’ hefty $33 mil­lion pay pack­age for 2017. Ian Read, you and your $28 mil­lion Pfiz­er deal, com­plete with $1 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times